155 related articles for article (PubMed ID: 37303494)
21. MicroRNA expression and clinical outcome of small cell lung cancer.
Lee JH; Voortman J; Dingemans AM; Voeller DM; Pham T; Wang Y; Giaccone G
PLoS One; 2011; 6(6):e21300. PubMed ID: 21731696
[TBL] [Abstract][Full Text] [Related]
22. Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
Motawi TM; Sadik NA; Shaker OG; El Masry MR; Mohareb F
Gene; 2016 Sep; 590(2):210-9. PubMed ID: 26827795
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.
Yang S; Li Y; Gao J; Zhang T; Li S; Luo A; Chen H; Ding F; Wang X; Liu Z
Oncogene; 2013 Sep; 32(36):4294-303. PubMed ID: 23001043
[TBL] [Abstract][Full Text] [Related]
24. High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer.
Tokumaru Y; Katsuta E; Oshi M; Sporn JC; Yan L; Le L; Matsuhashi N; Futamura M; Akao Y; Yoshida K; Takabe K
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32357442
[TBL] [Abstract][Full Text] [Related]
25. In bone metastasis miR-34a-5p absence inversely correlates with Met expression, while Met oncogene is unaffected by miR-34a-5p in non-metastatic and metastatic breast carcinomas.
Maroni P; Puglisi R; Mattia G; Carè A; Matteucci E; Bendinelli P; Desiderio MA
Carcinogenesis; 2017 May; 38(5):492-503. PubMed ID: 28334277
[TBL] [Abstract][Full Text] [Related]
26. Long Non-Coding RNA (LncRNA) UFC1/miR-34a Contributes to Proliferation and Migration in Breast Cancer.
Xie R; Wang M; Zhou W; Wang D; Yuan Y; Shi H; Wu L
Med Sci Monit; 2019 Sep; 25():7149-7157. PubMed ID: 31544897
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-34a Inhibition of the TLR Signaling Pathway Via CXCL10 Suppresses Breast Cancer Cell Invasion and Migration.
Xu M; Li D; Yang C; Ji JS
Cell Physiol Biochem; 2018; 46(3):1286-1304. PubMed ID: 29689563
[TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant Chemotherapy in Breast Cancer Patients Induces miR-34a and miR-122 Expression.
Frères P; Josse C; Bovy N; Boukerroucha M; Struman I; Bours V; Jerusalem G
J Cell Physiol; 2015 Feb; 230(2):473-81. PubMed ID: 25078559
[TBL] [Abstract][Full Text] [Related]
29. Abberent expression of oncogenic and tumor-suppressive microRNAs and their target genes in human adenocarcinoma alveolar basal epithelial cells.
Tafsiri E; Darbouy M; Shadmehr MB; Cho WC; Karimipoor M
J Cancer Res Ther; 2016; 12(1):395-400. PubMed ID: 27072269
[TBL] [Abstract][Full Text] [Related]
30. MiR-34a modulates ErbB2 in breast cancer.
Wang Y; Zhang X; Chao Z; Kung HF; Lin MC; Dress A; Wardle F; Jiang BH; Lai L
Cell Biol Int; 2017 Jan; 41(1):93-101. PubMed ID: 27813227
[TBL] [Abstract][Full Text] [Related]
31. miR-10b, miR-26a, miR-146a And miR-153 Expression in Triple Negative Vs Non Triple Negative Breast Cancer: Potential Biomarkers.
Fkih M'hamed I; Privat M; Trimeche M; Penault-Llorca F; Bignon YJ; Kenani A
Pathol Oncol Res; 2017 Oct; 23(4):815-827. PubMed ID: 28101798
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA signatures in hereditary breast cancer.
Murria Estal R; Palanca Suela S; de Juan Jiménez I; Egoavil Rojas C; García-Casado Z; Juan Fita MJ; Sánchez Heras AB; Segura Huerta A; Chirivella González I; Sánchez-Izquierdo D; Llop García M; Barragán González E; Bolufer Gilabert P
Breast Cancer Res Treat; 2013 Nov; 142(1):19-30. PubMed ID: 24129975
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients.
Hafez MM; Hassan ZK; Zekri AR; Gaber AA; Al Rejaie SS; Sayed-Ahmed MM; Al Shabanah O
Asian Pac J Cancer Prev; 2012; 13(2):591-8. PubMed ID: 22524830
[TBL] [Abstract][Full Text] [Related]
34. Expression level of human miR-34a correlates with glioma grade and prognosis.
Gao H; Zhao H; Xiang W
J Neurooncol; 2013 Jun; 113(2):221-8. PubMed ID: 23529798
[TBL] [Abstract][Full Text] [Related]
35. MicroRNAs miR-7 and miR-340 predict response to neoadjuvant chemotherapy in breast cancer.
Raychaudhuri M; Bronger H; Buchner T; Kiechle M; Weichert W; Avril S
Breast Cancer Res Treat; 2017 Apr; 162(3):511-521. PubMed ID: 28181130
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.
Li Y; Guessous F; Zhang Y; Dipierro C; Kefas B; Johnson E; Marcinkiewicz L; Jiang J; Yang Y; Schmittgen TD; Lopes B; Schiff D; Purow B; Abounader R
Cancer Res; 2009 Oct; 69(19):7569-76. PubMed ID: 19773441
[TBL] [Abstract][Full Text] [Related]
37. Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA.
Mackiewicz M; Huppi K; Pitt JJ; Dorsey TH; Ambs S; Caplen NJ
Breast Cancer Res Treat; 2011 Nov; 130(2):663-79. PubMed ID: 21814748
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
Ye J; Li L; Feng P; Wan J; Li J
Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
[TBL] [Abstract][Full Text] [Related]
39. p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC.
Christoffersen NR; Shalgi R; Frankel LB; Leucci E; Lees M; Klausen M; Pilpel Y; Nielsen FC; Oren M; Lund AH
Cell Death Differ; 2010 Feb; 17(2):236-45. PubMed ID: 19696787
[TBL] [Abstract][Full Text] [Related]
40. Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy.
Dalmasso B; Hatse S; Brouwers B; Laenen A; Berben L; Kenis C; Smeets A; Neven P; Schöffski P; Wildiers H
BMC Cancer; 2018 Oct; 18(1):1014. PubMed ID: 30348127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]